A phase I, open-label study to evaluate the safety, pharmacokinetic, pharmacodynamic, and clinical activity of PF-06863135, a B-cell maturation antigen/CD3 bispecific antibody, in patients with relapsed/refractory advanced multiple myeloma Meeting Abstract
| Authors: | Lesokhin, A. M.; Raje, N.; Gasparetto, C. J.; Walker, J.; Krupka, H. I.; Joh, T.; Taylor, C. T.; Jakubowiak, A. |
| Abstract Title: | A phase I, open-label study to evaluate the safety, pharmacokinetic, pharmacodynamic, and clinical activity of PF-06863135, a B-cell maturation antigen/CD3 bispecific antibody, in patients with relapsed/refractory advanced multiple myeloma |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454842801042 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-110427 |
| Notes: | Meeting Abstract: 3229 -- Source: Wos |
